IQVIA Unveils AI Agents at GTC Paris, Enhancing Workflows and Insights for Life Sciences

Strategic Insights -

IQVIA, a leading global provider of clinical research services, commercial insights, and healthcare intelligence, has introduced custom-built AI agents using NVIDIA technology to transform business processes and improve patient outcomes in the life sciences industry. The AI agents, developed through a strategic collaboration with NVIDIA, are designed to enhance workflows and accelerate insights for life sciences companies. Bhavik Patel, President of IQVIA Commercial Solutions, emphasized the importance of this collaboration, stating that it represents a pivotal opportunity to deliver precise and efficient workflows and insights required by the modern life sciences industry.

Key Takeaways:

  • IQVIA has introduced custom-built AI agents using NVIDIA technology to enhance workflows and accelerate insights for life sciences companies.
  • The AI agents are designed to help find breakthroughs and simplify operations across life sciences, with use cases including target identification, clinical data review, literature review, market assessment, and HCP engagement.
  • IQVIA's strategic collaboration with NVIDIA aims to build custom foundation models and agentic AI workflows to accelerate research, clinical development, and access to new treatments.
  • The collaboration has the potential to benefit thousands of IQVIA customers, allowing them to enhance, streamline, and focus clinical trials and commercial launches with powerful workflow coordination and insights.
  • Bhavik Patel, President of IQVIA Commercial Solutions, highlighted the significance of this collaboration, stating that it represents a pivotal opportunity to deliver precise and efficient workflows and insights required by the modern life sciences industry.
  • IQVIA's AI agents are being developed with the help of NVIDIA's NIM Agent Blueprints, NeMo Customizer, and NeMo Guardrails, allowing for rapid development, fine-tuning, and safeguarded deployment.

Statistics:

  • IQVIA has thousands of customers worldwide.
  • The life sciences industry can benefit from IQVIA and NVIDIA's collaboration, with potential improvements in clinical trial planning, clinical development, and access to new treatments.
  • IQVIA's AI agents have the potential to streamline clinical trials and commercial launches, enhancing workflow coordination and insights.

Sources:

  • [IQVIA press release: "IQVIA Unveils AI Agents at GTC Paris, Enhancing Workflows and Insights for Life Sciences"] (2023)
  • [NVIDIA press release: "NVIDIA and IQVIA Collaborate to Speed Medical Research and Development"] (2023)